Statistical Viewpoints on Designing Investigator Initiated Clinical Trials
Hamada, C.
Nihon Geka Gakkai Zasshi 116(3): 176-180
2015
ISSN/ISBN: 0301-4894 PMID: 26281659 Document Number: 684154
Document emailed within 1 workday
Related Documents
Elliott, G.A. 1970: The impact of clinical trials of drugs on the investigator, the industry and the country South African Medical Journal 44(1): 5-7Kingma, F.J. 1972: Role of the clinical investigator in clinical trials Journal of the American Veterinary Medical Association 161(11): 1389-1390
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Volf, E.M.; Au, S.-C.; Dumont, N.; Scheinman, P.; Gottlieb, A.B. 2012: A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis Journal of Drugs in Dermatology: Jdd 11(3): 341-346
Goadsby, P.J. 2003: Statistical methods in clinical trials Medical Journal of Australia 179(2): 119-20; Author Reply 120
Volkers, P. 2006: Clinical trials with allergen products--statistical considerations Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 95: 172-180; Discussion 181
Sylvester, R.; Collette, L. 1999: Statistical considerations of chemoprevention clinical trials in prostate cancer European Urology 35(5-6): 519-522
Schmale, A.H. 1980: Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part I. Introduction Cancer Treatment Reports 64(2-3): 441-443
O'Brien, F.B.; Stewart, W.C.; Sturtevant, F.M. 1983: Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis Contraception 27(2): 111-122
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Goldsmith, C.H. 1991: Challenges in designing antirheumatic drug trials Journal of Rheumatology 18(11): 1643-1644
French, J.A. 1993: Obstacles encountered in designing antiepileptic drug trials Epilepsy Research. Suppl 10: 81-89
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Kelly, J.A.; Spielberg, F.; McAuliffe, T.L. 2008: Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations Journal of Acquired Immune Deficiency Syndromes 47 Suppl. 1: S28-S33
Alam, N.; de Ven, P.M.van.; Oskam, E.; Stassen, P.; Kramer, M.Hh.; Exter, P.van.; Nanayakkara, P.Wb. 2016: Study protocol for a Multi-centre, Investigator-initiated, Randomized Controlled Trial to Compare the Effects of Prehospital Antibiotic Treatment for Sepsis Patients with Usual Care after Training Emergency Medical Services (EMS) Personnel in Early Recognition (- The Prehospital ANTibiotics Against Sepsis (PHANTASi) trial Acute Medicine 15(4): 176-184
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69